The differential role of A1 and A2 adenosine receptor subtypes in locomotor activity and place conditioning in rats

Behavioural Pharmacology

Volumn 7, Issue 4, 1996, Pages 373-383

  Brockwell, N T ^a   Beninger, R J ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

A1 and A2 receptors; Activity; Adenosine; CGS 15943A; CGS 21680; CPA; CPX; Place conditioning; Rat

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR AFFECTING AGENT; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; DRUG ANTAGONISM; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; NONHUMAN; PLACE PREFERENCE; RAT; REWARD;

EID: 0029793597     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199608000-00009     Document Type: Article

References (37)

1. Barraco RA, Coffin VL, Altman HJ and Phillis JW (1983) Central effects of adenosine analogs on locomotor activity in mice and antagonism of caffeine. Brain Research, 272, 392-395.
2. Barraco RA, Aggarwal AK, Phillis JW, Moron MA and Wu PH (1984) Dissociation of the locomotor and hypotensive effects of adenosine analogues in the rat. Neuroscience Letters, 48, 139-144.
3. Beninger RJ (1983) The role of dopamine in locomotor activity and learning. Brain Research Reviews, 6, 173-196.
4. Beninger RJ, Cooper TA and Mazurski EJ (1985) Automating the measurement of locomotor activity. Neurobehavioral Toxicology and Teratology, 7, 79-85.
5. Bozarth MA (1986) Neural basis of psychomotor stimulant and opiate reward: evidence suggesting a common dopaminergic system. Behavioral Brain Research, 22, 107-116.
6. Brockwell NT, Eikelboom R and Beninger RJ (1991) Caffeine-induced place and taste conditioning: production of dose-dependent preference and aversion. Pharmacology Biochemistry and Behavior, 38, 513-517.
7. Brockwell NT, Ferguson S and Beninger RJ (1996) A computerized system for the simultaneous monitoring of place conditioning and locomotor activity in rats. Journal of Neuroscience Methods, 64, 227-232.
8. 3H] NECA in rat striatal membranes. Molecular Pharmacology, 29, 331-346.
9. Bruns RF, Davis RE, Ninteman FW, Poschel BPH, Wiley JN and Heftier TG (1988) Adenosine antagonists as pharmacological tools. In: Physiology and Pharmacology of Adenosine and Adenine Nucleotides (Ed. DM Paton), pp. 39-49. Taylor and Francis, London.
10. Carr GD, Fibiger HC and Phillips AG (1989) Conditioned place preference as a measure of drug reward. In: The Neuropharmacological Basis of Reward (Eds JM Leibman and SJ Cooper), pp. 264-319. Oxford University Press, New York.
11. Costall B and Naylor RJ (1979) Behavioral aspects of dopamine agonists and antagonists. In: The Neurobiology of Dopamine (Eds AS Horn, J Korf and BHC Westernink), pp. 555-576. Academic Press, London.
12. Dunwiddie TV and Worth T (1982) Sedative and anticonvulsant effects of adenosine analogs in mouse and rat. Journal of Pharmacology and Experimental Therapeutics, 220, 70-75.
13. Durcan MJ and Morgan PF (1988) NECA-induced hypomotility in mice: evidence for a predominantly central site of action. Pharmacology Biochemistry and Behavior, 32, 487-490.
14. Durcan MJ and Morgan PF (1989) Evidence for adenosine A2 receptor involvement in the hypomobility effects of adenosine analogs in mice. European Journal of Pharmacology, 168, 285-290.
15. Finn IB and Holtzman SG (1987) Pharmacologic specificity of tolerance to caffeine-induced stimulation of locomotor activity. Psychopharmacology, 93, 428-434.
16. Ghia G, Francis J, Williams M, Zimmerman M, Goodman RF, Hopkins M and Cote D (1987) Pharmacological characterization of CGS 15943A, a novel, non-xanthine adenosine antagonist. Journal of Pharmacology and Experimental Therapeutics, 242, 784-790.
17. Griebel G, Saffroy-Spittler M, Misslin R, Remmy D, Vogel E and Bourguignon J-J (1991) Comparison of the behavioral effect of an adenosine A1/A2-receptor antagonist, CGS 15943A, and an A1-selective antagonist DPCPX. Psychopharmacology, 103, 541-544.
18. Harvey JA (1987) Behavioral pharmacology of central nervous system stimulants. Neuropharmacology, 26, 887-892.
19. Heffner TG, Wiley JN, Williams AE, Bruns RF, Coughenour LL and Downs DA (1989) Comparison of the behavioral effects of adenosine agonists and dopamine antagonists in mice. Psychopharmacology, 98, 31-37.
20. Hoffman DC (1989) The use of place conditioning in studying the neuropharmacology of drug reinforcement. Brain Research Bulletin, 23, 373-387.
21. Hoffman DC and Beninger RJ (1988) Selective D1 and D2 dopamine agonists produce opposing effects in place conditioning but not in conditioned taste aversion. Pharmacology Biochemistry and Behavior, 31, 1-8.
22. Holtzman SG (1991) CGS 15943, a nonxanthine adenosine receptor antagonist: effects on locomotor activity of non-tolerant and caffeine-tolerant rats. Life Sciences, 49, 1563-1570.
23. Hutchinson AJ, Webb RL, Oei HH, Ghia GR and Williams M (1989) CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity. Journal of Pharmacology and Experimental Therapeutics, 251, 47-55.
24. 3H]CGS 21680, an A2 selective adenosine receptor agonist, directly labels A2 receptors in rat brain tissue. Journal of Pharmacology and Experimental Therapeutics, 251, 888-893.
25. Keppel G (1982) Design and Analysis: A Researchers Handbook (2nd Edn). Prentice-Hall, Englewood Cliffs, NJ.
26. Linden J (1994) Purinergic systems. In: Basic Neurochemistry: Molecular, Cellular, and Medical Aspects (5th Edn) (Ed. GJ Seigel), pp. Raven Press, New York.
27. Mumford GK and Holtzman SG (1990) Methylxanthines elevate reinforcement threshold for electrical brain stimulation: role of adenosine receptors and phosphodiesterase inhibition. Brain Research, 459, 163-167.
28. Mumford GK and Holtzman SG (1991) Do adenosinergic substrates mediate methylxanthine effects upon reinforcement thresholds for electrical brain stimulation in the rat? Brain Research, 550, 172-178.
29. Mumford GK, Neill DB and Holtzman SG (1988) Caffeine elevates reinforcement threshold for electrical brain stimulation: tolerance and withdrawal changes. Brain Research, 459, 163-167.
30. 2-selective adenosine agonist. FEBS Letters, 261, 67-70.
31. Nikodijevic O, Sarges R, Daly JW and Jacobson KA (1991) Behavioral effects of A1- and A2-selective agonists and antagonists: evidence for synergism and antagonism. Journal of Pharmacological and Experimental Therapeutics, 259, 286-294.
32. Seale TW, Abla KA, Shamim MT, Carney JM and Daly JW (1988) 3,7-dimethyl-1-propargylxanthine: a potent and selective in vivo antagonist of adenosine analogs. Life Sciences, 43, 1671-1684.
33. Snyder SH, Katims JS, Annau Z, Brims RF and Daly JW (1981) Adenosine receptors and the actions of the methylxanthines. Proceedings of the National Academy of Sciences, 78, 3260-3264.
34. Swerdlow NR, Vaccarino FJ, Amalric M and Koob GF (1986) The neural substrates for the motor-activating properties of psychomotor stimulants: a review of recent findings. Pharmacology Biochemistry and Behavior, 25, 233-248.
35. Williams M (1989) Adenosine antagonists. Medicinal Research Reviews, 9, 219-243.
36. Williams M, Francis J, Ghia G, Braunwalder A, Psychoyos S, Stone GA and Cash WD (1987) Biochemical characterization of CGS 15943, a novel, non-xanthine adenosine antagonist. Journal of Pharmacology and Experimental Therapeutics, 214, 415-420.
37. Wise RA and Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychological Review, 94, 469-492.